These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 18632593)
1. 15-prostaglandin dehydrogenase expression alone or in combination with ACSM1 defines a subgroup of the apocrine molecular subtype of breast carcinoma. Celis JE; Gromov P; Cabezón T; Moreira JM; Friis E; Jirström K; Llombart-Bosch A; Timmermans-Wielenga V; Rank F; Gromova I Mol Cell Proteomics; 2008 Oct; 7(10):1795-809. PubMed ID: 18632593 [TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of apocrine carcinoma of the breast: validation of an apocrine protein signature in a well-defined cohort. Celis JE; Cabezón T; Moreira JM; Gromov P; Gromova I; Timmermans-Wielenga V; Iwase T; Akiyama F; Honma N; Rank F Mol Oncol; 2009 Jun; 3(3):220-37. PubMed ID: 19393583 [TBL] [Abstract][Full Text] [Related]
3. Apocrine cysts of the breast: biomarkers, origin, enlargement, and relation with cancer phenotype. Celis JE; Gromov P; Moreira JM; Cabezón T; Friis E; Vejborg IM; Proess G; Rank F; Gromova I Mol Cell Proteomics; 2006 Mar; 5(3):462-83. PubMed ID: 16316978 [TBL] [Abstract][Full Text] [Related]
4. Molecular pathology of breast apocrine carcinomas: a protein expression signature specific for benign apocrine metaplasia. Celis JE; Gromova I; Gromov P; Moreira JM; Cabezón T; Friis E; Rank F FEBS Lett; 2006 May; 580(12):2935-44. PubMed ID: 16631754 [TBL] [Abstract][Full Text] [Related]
5. FABP7 and HMGCS2 are novel protein markers for apocrine differentiation categorizing apocrine carcinoma of the breast. Gromov P; Espinoza JA; Talman ML; Honma N; Kroman N; Timmermans Wielenga V; Moreira JM; Gromova I PLoS One; 2014; 9(11):e112024. PubMed ID: 25389781 [TBL] [Abstract][Full Text] [Related]
6. Fine-needle aspiration cytologic features of four special types of breast cancers: mucinous, medullary, apocrine, and papillary. Haji BE; Das DK; Al-Ayadhy B; Pathan SK; George SG; Mallik MK; Abdeen SM Diagn Cytopathol; 2007 Jul; 35(7):408-16. PubMed ID: 17580344 [TBL] [Abstract][Full Text] [Related]
7. IMP3, a proposed novel basal phenotype marker, is commonly overexpressed in adenoid cystic carcinomas but not in apocrine carcinomas of the breast. Vranic S; Gurjeva O; Frkovic-Grazio S; Palazzo J; Tawfik O; Gatalica Z Appl Immunohistochem Mol Morphol; 2011 Oct; 19(5):413-6. PubMed ID: 21436679 [TBL] [Abstract][Full Text] [Related]
8. Characterization of breast precancerous lesions and myoepithelial hyperplasia in sclerosing adenosis with apocrine metaplasia. Celis JE; Moreira JM; Gromova I; Cabezón T; Gromov P; Shen T; Timmermans V; Rank F Mol Oncol; 2007 Jun; 1(1):97-119. PubMed ID: 19383289 [TBL] [Abstract][Full Text] [Related]
9. The expression of GHRH and its receptors in breast carcinomas with apocrine differentiation-further evidence of the presence of a GHRH pathway in these tumors. Kővári B; Vranic S; Marchio C; Sapino A; Cserni G Hum Pathol; 2017 Jun; 64():164-170. PubMed ID: 28438614 [TBL] [Abstract][Full Text] [Related]
10. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma. Tsutsumi Y Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930 [TBL] [Abstract][Full Text] [Related]
11. α-Methylacyl-CoA racemase: a useful immunohistochemical marker of breast carcinoma with apocrine differentiation. Nakamura H; Kukita Y; Kunimasa K; Kittaka N; Kusama H; Nakayama T; Tamaki Y; Sugiura R; Yasuda H; Hashimoto M; Yamamoto T; Imamura F; Nakatsuka SI Hum Pathol; 2021 Oct; 116():39-48. PubMed ID: 34314764 [TBL] [Abstract][Full Text] [Related]
12. Refinement of breast cancer classification by molecular characterization of histological special types. Weigelt B; Horlings HM; Kreike B; Hayes MM; Hauptmann M; Wessels LF; de Jong D; Van de Vijver MJ; Van't Veer LJ; Peterse JL J Pathol; 2008 Oct; 216(2):141-50. PubMed ID: 18720457 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemically defined subtypes and outcome of apocrine breast cancer. Dellapasqua S; Maisonneuve P; Viale G; Pruneri G; Mazzarol G; Ghisini R; Mazza M; Iorfida M; Rotmensz N; Veronesi P; Luini A; Goldhirsch A; Colleoni M Clin Breast Cancer; 2013 Apr; 13(2):95-102. PubMed ID: 23245877 [TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical and molecular profiling of histologically defined apocrine carcinomas of the breast. Vranic S; Marchiò C; Castellano I; Botta C; Scalzo MS; Bender RP; Payan-Gomez C; di Cantogno LV; Gugliotta P; Tondat F; di Celle PF; Mariani S; Gatalica Z; Sapino A Hum Pathol; 2015 Sep; 46(9):1350-9. PubMed ID: 26208846 [TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical analysis of apocrine breast lesions. Consistent over-expression of androgen receptor accompanied by the loss of estrogen and progesterone receptors in apocrine metaplasia and apocrine carcinoma in situ. Gatalica Z Pathol Res Pract; 1997; 193(11-12):753-8. PubMed ID: 9521507 [TBL] [Abstract][Full Text] [Related]
16. GATA3 expression in morphologic subtypes of breast carcinoma: a comparison with gross cystic disease fluid protein 15 and mammaglobin. Wendroth SM; Mentrikoski MJ; Wick MR Ann Diagn Pathol; 2015 Feb; 19(1):6-9. PubMed ID: 25544392 [TBL] [Abstract][Full Text] [Related]
17. Breast cancer molecular class ERBB2: preponderance of tumors with apocrine differentiation and expression of basal phenotype markers CK5, CK5/6, and EGFR. Bhargava R; Beriwal S; Striebel JM; Dabbs DJ Appl Immunohistochem Mol Morphol; 2010 Mar; 18(2):113-8. PubMed ID: 19801938 [TBL] [Abstract][Full Text] [Related]
18. E-cadherin immunohistochemical analysis of histiocytoid carcinoma of the breast. Gupta D; Croitoru CM; Ayala AG; Sahin AA; Middleton LP Ann Diagn Pathol; 2002 Jun; 6(3):141-7. PubMed ID: 12089723 [TBL] [Abstract][Full Text] [Related]
19. Pure Apocrine Carcinomas Represent a Clinicopathologically Distinct Androgen Receptor-Positive Subset of Triple-Negative Breast Cancers. Mills AM; E Gottlieb C; M Wendroth S; M Brenin C; Atkins KA Am J Surg Pathol; 2016 Aug; 40(8):1109-16. PubMed ID: 27259012 [TBL] [Abstract][Full Text] [Related]
20. Expression of apocrine differentiation markers in neuroendocrine breast carcinomas of aged women. Sapino A; Righi L; Cassoni P; Papotti M; Gugliotta P; Bussolati G Mod Pathol; 2001 Aug; 14(8):768-76. PubMed ID: 11504836 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]